Chunliang Liu

Title: Innovations of Chunliang Liu

Introduction

Chunliang Liu is a notable inventor based in Bellefonte, PA (US). He has made significant contributions to the field of biochemistry, particularly in the modulation of receptor-like protein tyrosine phosphatases. His innovative work has led to the development of a unique method for altering the redox equilibrium of these important enzymes.

Latest Patents

Chunliang Liu holds 1 patent for his invention titled "Boron-containing small molecules for inhibiting activity of a receptor-like protein tyrosine phosphatase." This patent discloses a method for chemically modulating the activity of a type IIa receptor-like protein tyrosine phosphatase (RPTP) through the use of diaryl boron compounds. The method allows for the alteration of the enzyme's redox state, which can be assessed both in vitro and in vivo.

Career Highlights

Throughout his career, Chunliang Liu has worked with prestigious organizations such as the Penn State Research Foundation and Cold Spring Harbor Laboratory. His research has focused on the biochemical pathways involving protein tyrosine phosphatases, contributing to a deeper understanding of their roles in cellular processes.

Collaborations

Chunliang Liu has collaborated with esteemed colleagues, including Stephen J Benkovic and Nicholas K Tonks. These partnerships have further enriched his research and expanded the impact of his innovations in the scientific community.

Conclusion

Chunliang Liu's contributions to the field of biochemistry through his innovative patent and collaborative efforts highlight his role as a significant inventor. His work continues to influence research in protein modulation and therapeutic applications.